Business Description
Nordic Nanovector ASA
ISIN : NO0010597883
Description
Thor Medical ASA is a company engaged in producing and supplying of alpha-particle emitters for cancer therapy. The production process is based on separation of natural occurring radioactive decay products from thorium (Th-232). The objective of the company is to supply alpha emitters to suppliers and developers of innovative drugs targeting indications of high unmet medical need, including any medical products and equipment, and to run business related thereto or associated therewith.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 32.89 | |||||
| Equity-to-Asset | 0.81 | |||||
| Debt-to-EBITDA | -0.05 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 83 | |||||
| 3-Year EPS without NRI Growth Rate | 82.4 | |||||
| 3-Year FCF Growth Rate | 59.8 | |||||
| 3-Year Book Growth Rate | -19.2 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.48 | |||||
| Quick Ratio | 6.48 | |||||
| Cash Ratio | 5.69 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -42.3 | |||||
| Shareholder Yield % | -0.13 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -6.86 | |||||
| ROA % | -5.51 | |||||
| ROIC % | -10.25 | |||||
| ROC (Joel Greenblatt) % | -1792.08 | |||||
| ROCE % | -8.18 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2.4 | |||||
| EV-to-EBIT | -42.01 | |||||
| EV-to-EBITDA | -43.73 | |||||
| EV-to-FCF | -28.26 | |||||
| Earnings Yield (Greenblatt) % | -2.38 | |||||
| FCF Yield % | -3.41 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:NRNVF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nordic Nanovector ASA Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | 0 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0 | ||
| 20-Day SMA ($) | 0 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 0 - 1.64 | ||
| Shares Outstanding (Mil) | 98.08 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nordic Nanovector ASA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nordic Nanovector ASA Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Nordic Nanovector ASA Frequently Asked Questions
What is Nordic Nanovector ASA(NRNVF)'s stock price today?
The current price of NRNVF is $1.64. The 52 week high of NRNVF is $1.64 and 52 week low is $0.00.
When is next earnings date of Nordic Nanovector ASA(NRNVF)?
The next earnings date of Nordic Nanovector ASA(NRNVF) is 2025-02-26.
Does Nordic Nanovector ASA(NRNVF) pay dividends? If so, how much?
Nordic Nanovector ASA(NRNVF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers